Status:
TERMINATED
Divalproex vs. Lamotrigine for Bipolar Disorder
Lead Sponsor:
Tuscaloosa Research & Education Advancement Corporation
Conditions:
Bipolar Disorder
Eligibility:
All Genders
19+ years
Brief Summary
This study is a retrospective chart review of patients treated for bipolar disorder at the TVAMC in the past four years cross-referenced with the electronic pharmacy file for having received a prescri...
Detailed Description
The primary objective of the study is to assess the long-term outcome in bipolar patients treated with divalproex versus lamotrigine in a retrospective chart review of veterans as measured by time to ...
Eligibility Criteria
Inclusion
- Diagnosis of Bipolar I or Bipolar II disorder
- Prescription of divalproex (any formulation except for Depakene/valproic acid) or lamotrigine in the electronic pharmacy profile.
- Age 19 or older
- Demonstrated stability for at least 4 weeks on an adequate dose of each medication (at least 50mg/d lamotrigine or 15mg/kg/day divalproex).
- Treatment at the TVAMC for at least 6 months following the prescription of divalproex or lamotrigine.
Exclusion
- Primary diagnosis of schizoaffective or schizophrenia during the evaluation period.
- Prescription of divalproex and lamotrigine given concurrently during the observation period.
- History of Dementia or cognitive disorders
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00451542
Start Date
February 1 2006
End Date
February 1 2008
Last Update
April 27 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.